Free Trial

Drägerwerk AG & Co. KGaA (ETR:DRW3) Shares Down 1.4% - What's Next?

Drägerwerk AG & Co. KGaA logo with Medical background

Drägerwerk AG & Co. KGaA (ETR:DRW3 - Get Free Report)'s stock price traded down 1.4% on Friday . The stock traded as low as €46.10 ($48.53) and last traded at €46.35 ($48.79). 7,117 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 33,804 shares. The stock had previously closed at €47.00 ($49.47).

Drägerwerk AG & Co. KGaA Stock Performance

The company has a market cap of $398.61 million, a P/E ratio of 7.51, a PEG ratio of 1.24 and a beta of -0.31. The company has a quick ratio of 0.81, a current ratio of 1.88 and a debt-to-equity ratio of 32.13. The company has a 50 day moving average price of €45.78 and a 200-day moving average price of €47.24.

About Drägerwerk AG & Co. KGaA

(Get Free Report)

Drägerwerk AG & Co KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ ⭕ [URGENT] Buy Alert just triggered (From Behind the Markets) (Ad)

Should you invest $1,000 in Drägerwerk AG & Co. KGaA right now?

Before you consider Drägerwerk AG & Co. KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Drägerwerk AG & Co. KGaA wasn't on the list.

While Drägerwerk AG & Co. KGaA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines